>
Wash Post Editorial Board Turns Against Climate Agenda?!
One Year Ago I Predicted and Described in Detail Huge Mars AI Plans that Elon Musk Confirmed...
British Teachers To "Spot Misogyny" In Boys And Target Them For Reeducation
Democrats Refuse To Release Post-Mortem Of 2024 Election Loss, DNC Chair Says
This tiny dev board is packed with features for ambitious makers
Scientists Discover Gel to Regrow Tooth Enamel
Vitamin C and Dandelion Root Killing Cancer Cells -- as Former CDC Director Calls for COVID-19...
Galactic Brain: US firm plans space-based data centers, power grid to challenge China
A microbial cleanup for glyphosate just earned a patent. Here's why that matters
Japan Breaks Internet Speed Record with 5 Million Times Faster Data Transfer
Advanced Propulsion Resources Part 1 of 2
PulsarFusion a forward-thinking UK aerospace company, is pushing the boundaries of space travel...
Dinky little laser box throws big-screen entertainment from inches away
'World's first' sodium-ion flashlight shines bright even at -40 ºF

In an interview with Saga magazine, the 84-year-old revealed that for the past two decades he has been paying a private Swiss clinic £17,000 every 12 to 18 months for stem cell therapy that he credits for looking "not bad" for his age. So is Cleese making a sound investment? Stem cells have remarkable medical potential. They are the body's master cells that, in the embryo, go on to produce every cell type in the body. Even in adulthood our body retains reserves of less versatile stem cells that mobilise to repair injuries and continually regenerate skin and other tissues.